SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-001052
Filing Date
2017-02-06
Accepted
2017-02-06 16:07:48
Documents
61
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1700102-10q.htm 10-Q 914894
2 EXHIBIT 31.1 t1700102_ex31-1.htm EX-31.1 6697
3 EXHIBIT 31.2 t1700102_ex31-2.htm EX-31.2 6673
4 EXHIBIT 32.1 t1700102_ex32-1.htm EX-32.1 2860
5 EXHIBIT 32.2 t1700102_ex32-2.htm EX-32.2 2764
  Complete submission text file 0001571049-17-001052.txt   4114815

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pahc-20161231.xml EX-101.INS 895814
7 XBRL SCHEMA FILE pahc-20161231.xsd EX-101.SCH 30296
8 XBRL CALCULATION FILE pahc-20161231_cal.xml EX-101.CAL 50817
9 XBRL DEFINITION FILE pahc-20161231_def.xml EX-101.DEF 101386
10 XBRL LABEL FILE pahc-20161231_lab.xml EX-101.LAB 294162
11 XBRL PRESENTATION FILE pahc-20161231_pre.xml EX-101.PRE 204114
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 17575683
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences